Unicycive Therapeutics Rings The Nasdaq Stock Market Closing Bell
Unicycive Therapeutics (Nasdaq: UNCY), a clinical stage biotechnology company developing therapies for patients with kidney disease, visits the Nasdaq MarketSite in Times Square to enhance awareness of renal disease and to commemorate National Kidney Month. In honor of the occasion, Shalabh Gupta, M.D., rings the Closing Bell.